Wells Fargo Maintains Underweight on Oscar Health, Raises Price Target to $14

Benzinga · 10/07/2025 14:06
Wells Fargo analyst Stephen Baxter maintains Oscar Health (NYSE:OSCR) with a Underweight and raises the price target from $10 to $14.